Milton C. Weinstein

Harvard University — United States

Economics, Econometrics and Finance · Social Sciences

110h-index46.4kcitations452works1.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(183), HIV/AIDS Research and Interventions(78), Healthcare Policy and Management(61), Healthcare cost, quality, practices(60), HIV/AIDS drug development and treatment(54)

Publications452 total

Modeling the Cost-Effectiveness of the COVID-19 mRNA-1273 vaccine in the United States
2025· 1 citedOpen Access
Modeling the Cost-Effectiveness of the Next-Generation COVID-19 mRNA-1283 vaccine in the United States
2025· 1 citedOpen Access
Modeling the Anticipated Public Health Benefits of the Next-Generation COVID-19 mRNA-1283 vaccine: An Interim U.S. Population-Level Impact Assessment
2025· 2 citedOpen Access
The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir–lamivudine–dolutegravir in South Africa: a modelling study
The Lancet HIV·2025· 1 citedOpen Access
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care
The Lancet Global Health·2025Open Access
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens
PLoS ONE·2025· 3 citedOpen Access
Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections
UNC Libraries·2024Open Access
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States
Journal of Medical Economics·2023· 25 citedOpen Access
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study
2023· 2 citedOpen Access
Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price
Clinical Infectious Diseases·2023· 7 citedOpen Access
The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling Analysis
MDM Policy & Practice·2023· 10 citedOpen Access
Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings
SPIRE - Sciences Po Institutional REpository·2023Open Access
Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings
Journal of the International AIDS Society·2023· 18 citedOpen Access
116. Potential Clinical Impact of Respiratory Syncytial Virus (RSV) Vaccination in Older Adults in the United States
Open Forum Infectious Diseases·2022· 1 citedOpen Access
The potential clinical impact of implementing different COVID-19 boosters in fall 2022 in the United States
Journal of Medical Economics·2022· 10 citedOpen Access
The Potential Clinical Impact of Implementing Different COVID-19 Boosters in Fall 2022 in the United States
2022Open Access
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India
AIDS·2022· 3 citedOpen Access
An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom
Vaccines·2022· 4 citedOpen Access
The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
Human Vaccines & Immunotherapeutics·2021· 16 citedOpen Access
The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom
Vaccines·2021· 12 citedOpen Access
page 1 of 23Next →

Frequent Co-authors

Peter J. Neumann(8), Joseph S. Pliskin(6), A. David Paltiel(5), Elena Losina(5), William B. Stason(4), Sue J. Goldie(4), Jane C. Weeks(4), Paula A. Goldman(3), M. G. Myriam Hunink(3), Rochelle P. Walensky(3), April D. Kimmel(3), George R. Seage(3), Kenneth A. Freedberg(3), Thomas A. Gaziano(3), Karen M. Kuntz(3), Joshua T. Cohen(2), Donald M. Berwick(2), Magnus Johannesson(2), Andrew Briggs(2), Elisabeth Fenwick(2)